Citius Oncology Net Tangible Assets

Citius Oncology (CTOR) currently reports a net tangible assets of $35M as of March 2026. That compares with $36M in the prior-year period — down 1.0% year over year. Use the charts on this page to explore Citius Oncology's net tangible assets history and peer comparisons.

Citius Oncology's net tangible assets decreased from $36M to $35M — a 1.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Citius Oncology reported $35M in net tangible assets as of March 2026. That compares with $36M in the prior-year period — down 1.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Citius Oncology, and consider following CTOR for alerts when major investors trade the stock.